Gail H Cassell

Gail H Cassell, Ph.D.

Bio
Research
Publications

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants.

Authors: Authors: Cassell GH, Waites KB, Crouse DT, Rudd PT, Canupp KC, Stagno S, Cutter GR.
Lancet 1988-07-30
View full abstract on Pubmed

Prevalence rates of infectious agents among commercial breeding populations of rats and mice.

Authors: Authors: Casebolt DB, Lindsey JR, Cassell GH.
Lab Anim Sci 1988-06-01
View full abstract on Pubmed

Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis.

Authors: Authors: Watson HL, McDaniel LS, Blalock DK, Fallon MT, Cassell GH.
Infect Immun 1988-05-01
View full abstract on Pubmed

Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants.

Authors: Authors: Waites KB, Rudd PT, Crouse DT, Canupp KC, Nelson KG, Ramsey C, Cassell GH.
Lancet 1988-01-02
View full abstract on Pubmed

Protein antigens of genital mycoplasmas.

Authors: Authors: Cassell GH, Watson HL, Blalock DK, Horowitz SA, Duffy LB.
Rev Infect Dis 1988-01-01
View full abstract on Pubmed

Genital Mycoplasma infections in neonates.

Authors: Authors: Waites KB, Cassell GH.
J Pediatr 1988-01-01
View full abstract on Pubmed

Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice.

Authors: Authors: Parker RF, Davis JK, Blalock DK, Thorp RB, Simecka JW, Cassell GH.
Infect Immun 1987-11-01
View full abstract on Pubmed

Protein variability among strains of Mycoplasma pulmonis.

Authors: Authors: Watson HL, Davidson MK, Cox NR, Davis JK, Dybvig K, Cassell GH.
Infect Immun 1987-11-01
View full abstract on Pubmed

Chronic recurrent multifocal osteomyelitis: are mycoplasmas involved?

Authors: Authors: Hummell DS, Anderson SJ, Wright PF, Cassell GH, Waites KB.
N Engl J Med 1987-08-20
View full abstract on Pubmed

Diagnosis of murine mycoplasmal infections by enzyme-linked immunosorbent assay (ELISA).

Authors: Authors: Davis J, Cassell GH, Gambill G, Cox N, Watson H, Davidson M.
Isr J Med Sci 1987-06-01
View full abstract on Pubmed